Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bonucchi, D.
Right arrow Articles by Albertazzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonucchi, D.
Right arrow Articles by Albertazzi, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 20-22
© 2002 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Which is the preferred vascular access in diabetic patients? A view from Europe

Decenzio Bonucchi, Gianni Cappelli and Alberto Albertazzi

Nephrology, Dialysis and Transplantation, University Hospital, Modena, Italy

Keywords: diabetes; vascular access

Introduction

After 35 years of experience with dialysis treatment, the prompt availability of a well-functioning, stable vascular access remains a disturbing problem, compared with the successful solutions formed for renal anaemia, water purity, biocompatibility and others. This is especially true when dealing with the issue of vascular access in diabetic patients, in which the increasing prevalence of the disease and the severity of vascular damage demand special efforts of the health staff.

Which kind of diabetes?

Proper classification of diabetes in end-stage renal disease is still a problem, mainly due to misinterpretation of the use of insulin treatment. It is clear that at present, from a clinical point of view, two different diseases are frequently taken together.

With vascular access (VA), type 2 diabetes adds the effect of ageing to that of the vascular alterations linked to the basic disease [. . . [Full Text of this Article]

Strategy or technique?

Different attitudes?

Conclusions

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al.
Bone disease after renal transplantation
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. K. Lazarides, G. S. Georgiadis, V. D. Tzilalis, and D. Bonucchi
Diabetes should not preclude efforts for creation of a primary radiocephalic fistula
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1852 - 1854.
[Full Text]

Home page
 Nephrol Dial TransplantHome page
J. Pengloan, R. Vanholder, and H. Hoeben
Vascular access: care and monitoring
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1141 - 1145.
[Full Text] [PDF]